Page last updated: 2024-08-26

wr 1065 and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

wr 1065 has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhavsar, T; Hahn, PJ; Hatoum, GF; Nevaldine, B; Phung, Q	1

Other Studies

1 other study(ies) available for wr 1065 and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

Article	Year
WR-1065, the active form of amifostine, protects HL-60 cells but not peripheral blood mononuclear cells from radiation and etoposide-induced apoptosis. International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Survival; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Leukocytes, Mononuclear; Mercaptoethylamines; Radiation-Protective Agents	2004

Article

Year

WR-1065, the active form of amifostine, protects HL-60 cells but not peripheral blood mononuclear cells from radiation and etoposide-induced apoptosis.

International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Survival; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Leukocytes, Mononuclear; Mercaptoethylamines; Radiation-Protective Agents

2004